Geode Capital Management’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $776K | Buy |
230,275
+4,458
| +2% | +$15K | ﹤0.01% | 3414 |
|
|
2025
Q1 | $343K | Buy |
225,817
+17,430
| +8% | +$26.5K | ﹤0.01% | 3677 |
|
|
2024
Q4 | $459K | Sell |
208,387
-1,254
| -0.6% | -$2.76K | ﹤0.01% | 3624 |
|
|
2024
Q3 | $522K | Sell |
209,641
-12,160
| -5% | -$30.3K | ﹤0.01% | 3569 |
|
|
2024
Q2 | $284K | Sell |
221,801
-240,719
| -52% | -$308K | ﹤0.01% | 3786 |
|
|
2024
Q1 | $1.34M | Buy |
462,520
+18,287
| +4% | +$52.9K | ﹤0.01% | 3254 |
|
|
2023
Q4 | $3.27M | Buy |
444,233
+11,529
| +3% | +$84.7K | ﹤0.01% | 2908 |
|
|
2023
Q3 | $3.32M | Buy |
432,704
+44,378
| +11% | +$341K | ﹤0.01% | 2850 |
|
|
2023
Q2 | $3.94M | Buy |
388,326
+219,107
| +129% | +$2.22M | ﹤0.01% | 2819 |
|
|
2023
Q1 | $1.64M | Hold |
169,219
| – | – | ﹤0.01% | 3114 |
|
|
2022
Q4 | $820K | Sell |
169,219
-372
| -0.2% | -$1.8K | ﹤0.01% | 3448 |
|
|
2022
Q3 | $2.43M | Buy |
169,591
+94,991
| +127% | +$1.36M | ﹤0.01% | 3021 |
|
|
2022
Q2 | $403K | Sell |
74,600
-163,816
| -69% | -$885K | ﹤0.01% | 3882 |
|
|
2022
Q1 | $1.54M | Buy |
238,416
+104,601
| +78% | +$677K | ﹤0.01% | 3389 |
|
|
2021
Q4 | $2.16M | Buy |
133,815
+11,496
| +9% | +$186K | ﹤0.01% | 3330 |
|
|
2021
Q3 | $3.25M | Buy |
+122,319
| New | +$3.25M | ﹤0.01% | 3152 |
|